EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.24.68 | Adenoma, Islet Cell |
6750614 |
Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
4
1
0 |
| 3.4.24.68 | Anthrax |
2907687 |
Mosquito inoculation: an alternative bioassay for toxins. |
therapeutic application
unassigned |
1
0 |
| 3.4.24.68 | Anthrax |
7929330 |
Cytotoxic effects of a chimeric protein consisting of tetanus toxin light chain and anthrax toxin lethal factor in non-neuronal cells. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 3.4.24.68 | Anthrax |
15193401 |
Pluronic F127-based systemic vaccine delivery systems. |
diagnostic usage
ongoing research
unassigned |
4
3
0 |
| 3.4.24.68 | Anthrax |
15657483 |
Application of NMR methods to identify detection reagents for use in development of robust nanosensors. |
causal interaction
unassigned |
1
0 |
| 3.4.24.68 | Anthrax |
15797567 |
Antibody microarrays for native toxin detection. |
diagnostic usage
therapeutic application
unassigned |
4
1
0 |
| 3.4.24.68 | Anthrax |
19253949 |
Self-assembled peptide monolayers as a toxin sensing mechanism within arrayed microchannels. |
unassigned |
0 |
| 3.4.24.68 | Anthrax |
19866821 |
THE IMMUNIZING POWER OF NUCLEOHISTON AND OF HISTON. |
therapeutic application
unassigned |
1
0 |
| 3.4.24.68 | Anthrax |
19914191 |
Mucosal delivery of antigens using adsorption to bacterial spores. |
therapeutic application
unassigned |
2
0 |
| 3.4.24.68 | Anthrax |
22214451 |
Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs. |
therapeutic application
unassigned |
4
0 |
